respiratory-syncytial-virus

Documents about respiratory-syncytial-virus

• Infection With Respiratory Syncytial Virus in Infants#1409994ClinicalTrials.gov
• Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus#860388ClinicalTrials.gov
• Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants#1339271ClinicalTrials.gov
• Estimating cumulative incidence from partially missing time series of respiratory viral infections#928037PLOS
• Respiratory Syncytial Virus - RSV Protocol#1228896ClinicalTrials.gov
• Inflammatory Mediators Associated With Infection by Respiratory Syncytial Virus#1101836ClinicalTrials.gov
• First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory#1381671ClinicalTrials.gov
• Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)#877103ClinicalTrials.gov
• Assessing Antiviral Treatments in Early Symptomatic RSV#162526ClinicalTrials.gov
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract#1394495ClinicalTrials.gov
• TARSILA Real-World Evidence Study#1073254ClinicalTrials.gov
• The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory#830625ClinicalTrials.gov
• Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines#1376975ClinicalTrials.gov
• Evidence mapping of preference elicitation for non-pharmaceutical interventions targeting respiratory viral transmission: A scoping review protocol#240431PLOS
• RSV Vaccine Pregnancy Registry#1074932ClinicalTrials.gov
• The Development of a Human Model of Respiratory Syncytial Virus Infection#1196308ClinicalTrials.gov
• "Palivizumab Therapy for RSV-bronchiolitis"#897828ClinicalTrials.gov
• From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virus.#289157PubMed
• Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection#842546ClinicalTrials.gov
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children#1137844ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine#249663ClinicalTrials.gov
• rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older#1281081ClinicalTrials.gov
• Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults#181583ClinicalTrials.gov
• Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)#350024ClinicalTrials.gov
• A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine#651123ClinicalTrials.gov
• Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review#784677Europe PMC
• A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease#125947ClinicalTrials.gov
• Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children#847401ClinicalTrials.gov
• Assessing the Burden of Respiratory Syncytial Virus (RSV)#1422130ClinicalTrials.gov
• Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study#5093Europe PMC
• Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections#1059196ClinicalTrials.gov
• Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection#1451954ClinicalTrials.gov
• Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women#268058ClinicalTrials.gov
• A Study of ALS-008176 in Infants Hospitalized With RSV#857350ClinicalTrials.gov
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection#917129ClinicalTrials.gov
• Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection#1151662ClinicalTrials.gov
• STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)#981266ClinicalTrials.gov
• Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly#1485915ClinicalTrials.gov
• Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children#217110ClinicalTrials.gov
• Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease#811039ClinicalTrials.gov
• Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017)#1059319ClinicalTrials.gov
• A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection#1484040ClinicalTrials.gov
• Respiratory syncytial virus sequencing considerations for an expanded Global Influenza Surveillance and Response System#216370WHO IRIS
• A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults#811715ClinicalTrials.gov
• A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN#1421914ClinicalTrials.gov
• A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections#801715ClinicalTrials.gov
• A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults#1111478ClinicalTrials.gov
• A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults#398198ClinicalTrials.gov
• Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children#881446ClinicalTrials.gov
• An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants#881591ClinicalTrials.gov